Amanda M De Hoedt

14PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 24, 2025
Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancer.

Stephen J Freedland, Agnes Hong, Nader El-Chaar

|Jul 04, 2025
Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer.

Nadine A Friedrich, Jessica L Janes, Joshua Parrish

|Nov 14, 2024
Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance.

Ali H Zahalka, Ethan Fram, Evan Garden

|Nov 01, 2024
Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer.

Nadine Friedrich, Nadine Friedrich, Jessica Janes

|Apr 29, 2024
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system.

Kelly K Bree, Jessica L Janes, Patrick J Hensley

|Oct 27, 2023
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?

Jun Gong, Daniel M Kim, Amanda M De Hoedt

Pageof 3

Frequent Collaborators

11 joint publications

Stephen J Freedland

4 joint publications

Lauren Howard

4 joint publications

Zachary Klaassen

3 joint publications

Joshua Parrish